Table 5.
Evaluation | Evaluation index | Evaluation methods | ||
---|---|---|---|---|
In vitro | Interfacial bonding strength | Sufficient bonding strength | Shear testing and peel testing | |
Cell compatibility | Cell adhesion and viability | SEM and live/dead staining | ||
Chondrogenic differentiation | Chondrogenic markers | SOX9 | Immunofluorescence staining | |
Col-II | ||||
Aggrecan (ACAN) | ||||
Chondrogenic gene expression | Real time-PCR (RT-PCR) procedure | |||
Production of glycosaminoglycan (GAG) | Toluidine blue and sarfranin O staining | |||
Osteogenic differentiation | Osteogenic markers | RUNX2 | Immunofluorescence staining Alkaline phosphatase (ALP) staining |
|
Osteocalcin (OCN) | ||||
Alkaline phosphatase (ALP) | ||||
Osteogenic gene expression | Real time-PCR (RT-PCR) procedure | |||
Calcium deposition | Alizarin RedS (ARS) staining/von Kossa | |||
In vivo (animal model) | Macroscopic assessment | Gross morphology assessment scores using modified Wayne's grading scale | Based on the degree of defect repair, degree of integration and macroscopic appearance | |
Microcomputed tomography (micro CT) | Percentage bone volume over total volume (% BV/TV) | Scanco Medical 40 Micro CT system | ||
Histological analysis | Repair tissue morphology, composition and arrangement, cell ECM production and scaffold degradation | Hematoxylin and Eosin (H&E) staining | ||
The presence of proteoglycans | Toluidine blue staining | |||
Production of Glycosaminoglycans | Safranin-O/Fast green staining | |||
Collagen | Masson's trichrome staining | |||
Fibrin and collagen fibres | Movat's pentachrome/Sirius red staining(in vitro) | |||
Immunohistochemistry analysis | Formation of type II collagen | Collagen were incubated with specific antibody | ||
Biomechanical | Modulus, Permeability, Poisson's ratio | Custom-designed indentation apparatus |